Ptc Therapeutics (PTCT) Change in Inventory (2017 - 2026)

Ptc Therapeutics' Change in Inventory history runs 10 years deep, the most recent figure standing at -$2.6 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 20.63% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was $53.4 million, a 748.99% increase from a year earlier, with the FY2025 full-year figure at $53.9 million, up 974.37% from the prior year.
• Change in Inventory retreated to -$2.6 million in Q1 2026 per PTCT's latest filing, from $26.8 million in the prior quarter.
• Across five years, Change in Inventory topped out at $26.8 million in Q4 2025 and bottomed at -$11.1 million in Q4 2024.
• The 5-year median for Change in Inventory is $1.9 million (2024), against an average of $3.5 million.
• Across the five-year window, Change in Inventory jumped 1504.64% in 2023 and plunged 1725.83% in 2025, its largest moves.
• Year by year, Change in Inventory stood at $5.9 million in 2022, then tumbled by 200.64% to -$5.9 million in 2023, then sank by 86.7% to -$11.1 million in 2024, then soared by 341.56% to $26.8 million in 2025, then tumbled by 109.87% to -$2.6 million in 2026.
• Per Business Quant, the three latest PTCT Change in Inventory figures stand at -$2.6 million (Q1 2026), $26.8 million (Q4 2025), and $18.5 million (Q3 2025).